Stock LYTIX LYTIX BIOPHARMA
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Lytix Biopharma

Equities

LYTIX

NO0010405780

Market Closed - Oslo Bors
Other stock markets
 15:45:00 31/05/2024 BST 		5-day change 1st Jan Change
6.4 NOK +1.59% Intraday chart for Lytix Biopharma +6.67% +31.69%
05-30 Transcript : Lytix Biopharma AS, Q1 2024 Earnings Call, May 30, 2024
04-25 Lytix Biopharma Announces Approval of the Phase II Study in Early-Stage Skin Cancer Representing A Significant Commercial Opportunity CI

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LYTIX Stock
  4. News Lytix Biopharma
  5. Analyst Reco.